Pricing Log in Create free account

Silexion Therapeutics Corp (SLXN) vs XORTX Therapeutics Inc. (XRTX)

Silexion Therapeutics Corp and XORTX Therapeutics Inc. are both Biotechnology companies. Silexion Therapeutics Corp and XORTX Therapeutics Inc. are of similar size ($2.7M and $2.6M). Across the 9 metrics below, XORTX Therapeutics Inc. leads on 7 and Silexion Therapeutics Corp on 2.

Valuation

Metric SLXN XRTX Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B 2.34 0.36 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.04 n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield (14,489.87%) (220.16%) (33.15%)
Free cash flow yield (12,070.84%) (263.28%) (25.50%)

Profitability

Metric SLXN XRTX Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (17,021.95%) (99.24%) (56.36%)
Return on assets (277.96%) (83.78%) (48.04%)
Return on invested capital 0.00% (54.27%) 0.00%

Growth

Metric SLXN XRTX Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 97.73% 51.30% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric SLXN XRTX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.94 3.59 4.72
Net debt to EBITDA 0.38 0.28 0.96

Dividend

Metric SLXN XRTX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric SLXN XRTX Biotechnology median
Market cap 2.73m 2.58m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack